Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: September 2014

14 - Complications and safety

Related content

Powered by UNSILO

References

1. WHO. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health Organization, 2012.
2. WHO. Unsafe Abortion: Global and Regional Estimates of the Incidence of Unsafe Abortion and Associated Mortality in 2008, 6th edn. Geneva: World Health Organization, 2011.
3. Saucedo M, Deneux-Tharaux C, Bouvier-Colle M-H. Ten years of confidential inquiries into maternal deaths in France, 1998–2007. Obstet Gynecol 2013;122:752–60.
4. Schulz KF, Grimes DA, Cates W. Measures to prevent cervical injury during suction curettage abortion. Lancet 1983;1:1182–4.
5. Zhou W, Nielsen GL, Moller M, Olsen J. Short-term complications after surgically induced abortions: a register-based study of 56 117 abortions. Acta Obstet Gynecol Scand 2002;81:331–6.
6. Saxena R. Tips and Tricks in Operative Obstetrics and Gynecology. Jaypee Brothers Medical Pub., 2011: 243.
7. Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility, 8th edn. Wolters Kluwer/Lippincott Williams & Wilkins, 2011.
8. Royal College of Obstetricians and Gynaecologists. The Care of Women Requesting Induced Abortion. Evidence-based Clinical Guideline Number 7. November 2011.
9. Ben-Ami I, Schneider D, Svirsky R, Smorgick N, Pansky M, Halperin R. Safety of late second-trimester pregnancy termination by laminaria dilatation and evacuation in patients with previous multiple cesarean sections. Am J Obstet Gynecol 2009;201:154 e151–5.
10. Cooper JM, Brady RM. Intraoperative and early postoperative complications of operative hysteroscopy. Obstet Gynecol Clin North Am 2000;27:347–66.
11. Hern WM. Surgical abortion: management, complications, and long term risks. In JJ Sciarra, PV Dilts (eds.) Gynecology and Obstetrics. Philadelphia: J.B. Lippincott Company, 1994: Chapter 59.
12. Lindell G, Flam F. Management of uterine perforations in connection with legal abortions. Acta Obstet Gynecol Scand 1995;74:373–5.
13. Kerns J, Steinauer J. Management of postabortion hemorrhage: release date November 2012 SFP Guideline #20131. Contraception 2013;87:331–42.
14. Borgatta, L, Kattan, D, et al. Surgical techniques for first-trimester abortion. Glob Libr Women’s Med 2012; DOI 10.3843/GLOWM.10440.
15. Peterson HB, Grimes DA, Cates W, Rubin GL. Comparative risk of death from induced abortion at less than or equal to 12 weeks’ gestation performed with local versus general anesthesia. Am J Obstet Gynecol 1981;141:763–8.
16. Larrson PG, Platz-Christensen JJ, Theijls H, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized trial. Am J Obstet Gynecol 1992;166:100.
17. Faucher P, Hassoun D. Interruption Volontaire de la Grossesse médicamenteuse, 2nd edn. de Boeck/Estem, 2011.
18. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994;9:2167–72.
19. Chan YF, Ho PC, Ma HK. Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost. Contraception 1993;47:85–95.
20. Niinimäki M, Pouta A, Bloigu A, et al. Immediate complications after medical compared with surgical termination of pregnancy. Obstet Gynecol 2009;114:795–804.
21. Allen RH, Westhoff C, De Nonno L, Fielding SL, Schaff EA. Curettage after mifepristone-induced abortion. Frequency, timing and indications. Obstetr Gynecol 2001;98:101–6.
22. ICMA. ICMA Information Package on Medical Abortion. www.medicalabortionconsortium.org/articles/for-health-care-providers/health/?bl=en (accessed 31 October 2013).
23. Gynuity. Providing Medical Abortion in Developing Countries: An Introductory Guidebook. New York: Gynuity Health Projects, 2004.
24. Shannon C, Brothers LP, Philip NM, Winikoff B. Infection after medical abortion: a review of the literature. Contraception 2004;70:183–90.
25. Meites E, Zane S, Gould C. Fatal Clostridium sordellii infections after medical abortions. New England Journal of Medicine 2010;363:1382–3.
26. Fjerstad M, Trussell J, Sivin I, Lichtenberg ES, Cullins V. Rates of serious infection after changes in regimens for medical abortion. New England Journal of Medicine 2009;361:145–51.
27. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 2002;109:1281–9.
28. Diop A, Raghavan S, Rakotovao J-P, Comendant R, Blumenthal PD, Winikoff B. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception 2009;79:456–62.
29. Autry AM, Hayes C, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. American Journal of Obstet Gynecol 2002;187:393–7.
30. Goyal V. Uterine rupture in second-trimester misoprostol-induced abortion after cesarean delivery: a systematic review. Obstet Gynecol 2009;113:1117–23.
31. Shannon CS, Winikoff B, eds. Misoprostol: An Emerging Technology for Women’s Health. Report of a Seminar: May 7–8, 2001. New York: Population Council, 2004.